| Financial Year |
March 31 2023 |
| Monetary Funds |
851,780,325.04 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,092,146,233.63 |
| Advances to Suppliers |
147,781,374.22 |
| Other Receivables |
79,373,832.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
6,819,800.00 |
| Inventories |
477,498,188.26 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
45,669,168.67 |
| Total Current Assets |
2,736,682,512.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
533,499,473.89 |
| Investment Properties |
130,788,797.20 |
| Fixed Assetes |
4,910,854,950.06 |
| Under-construction Projects |
608,453,714.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
529,683,628.19 |
| R&D expenses |
-- |
| Goodwill |
77,738,157.95 |
| Long-Term Deferred and Prepaid Expenses |
199,369,245.55 |
| Deferred Income Tax Assets |
89,120,997.26 |
| Other Non-Current Assets |
490,808,456.77 |
| Sub-Total of Non-Current Assets |
7,734,424,365.52 |
| Total Assets |
10,471,106,877.66 |
| Short-Term Loans |
3,065,760,965.19 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
548,335,794.71 |
| Accounts Received In Advance |
866,375.57 |
| Employee Compensation Payable |
27,533,714.03 |
| Taxes Payable |
52,539,440.63 |
| Interest Payable |
1,286,954.00 |
| Dividend Payable |
-- |
| Other payables |
128,620,044.80 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
460,413,372.38 |
| Other Current Liabilities |
8,575,222.20 |
| Sub-Total of Current Liabilities |
4,844,649,517.01 |
| Long-term Loans |
722,530,990.65 |
| Bonds Payable |
855,181,743.46 |
| Long-Term Accounts Payable |
132,118,641.32 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
22,839,302.48 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,794,899,284.20 |
| Total Liabilities |
6,639,548,801.21 |
| Paid-In Capital(Or Share Stock) |
1,138,262,566.00 |
| Capital Surplus |
194,307,414.03 |
| Surplus Reserve |
48,952,802.50 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,372,965,358.45 |
| Minority Stockholder's Interest |
786,397,852.38 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,045,160,224.07 |
| Owner's Equity（Stockholder's Equity） |
3,831,558,076.45 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,471,106,877.66 |
